What ICS does

ICS is the United States pharmaceutical third-party logistics (3PL) brand operating as a wholly-owned subsidiary of Cencora (NYSE: COR), a Fortune 500 healthcare services company. Founded in 1997 and headquartered in Carrollton, Texas, ICS provides warehousing, storage, transportation, and order fulfillment services to pharmaceutical and biotech manufacturers, with particular specialization in cold chain logistics spanning cryogenic, refrigerated, ambient, and controlled-drug temperature regimes. The company handles high-value, regulated product categories including gene therapies, biosimilars, generic pharmaceuticals, APIs, and medical devices, with capabilities extending to GMP-compliant repackaging, relabeling, pharmaceutical serialization, and import/export compliance.

The platform is architected around an integrated technology stack that includes a Warehouse Management System (WMS), Enterprise Resource Planning (ERP) integration, Electronic Data Interchange (EDI) for automated document exchange, a multi-country portal for cross-border coordination, and a track-and-trace portal providing live shipment visibility. Value-added service modules include order-to-cash processing, title model solutions, fourth-party logistics (4PL) project management, and dedicated cell and gene therapy (CGT) logistics. ICS operates as one node within Cencora's broader 3PL network of approximately 45 sites across 16 countries, sitting alongside sister brands Alloga (Europe), Innomar (Canada/specialty), and World Courier (global specialized transport).

ICS generates revenue through managed services contracts with pharmaceutical manufacturers, charging for storage capacity, handling, transportation, and value-added services on a quote-based, contract-negotiated basis. Pricing is not publicly disclosed. Go-to-market is enterprise field sales targeting pharma and biotech manufacturers through Cencora's global account management infrastructure, with a consultative selling motion addressing complex, compliance-driven supply chain requirements. The firmographic listing shows 251-500 direct employees at ICS; the broader Cencora 3PL team comprises 3,700+ members serving 700+ clients globally.

Name

ICS

Legal name

ICS

Website

https://icsconnect.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

ICS is the US pharmaceutical third-party logistics (3PL) brand of Cencora, providing warehousing, cold chain storage, transportation, order fulfillment, and GMP-compliant value-added services to pharmaceutical and biotech manufacturers across Cencora's global 16-country network.

Ownership category

akta.pro rank

Headquarters

HQ city

Carrollton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Third-Party Logistics Services: ICS provides pharmaceutical 3PL services including warehousing, storage, transportation, order fulfillment, and value-added services to pharmaceutical manufacturers. Revenue is generated through managed logistics contracts with pharmaceutical companies, charging for storage capacity, handling, transportation, and additional services like repackaging, kitting, and labeling.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

ICS is a pharmaceutical third-party logistics (3PL) provider that distributes gene therapy products, generic pharmaceuticals, biosimilars, and medical devices. Operating as the US arm of Cencora's global 3PL network, ICS delivers warehousing, storage, temperature-controlled transport, order fulfillment, packaging and labeling, serialization, and cold chain management services to pharmaceutical and healthcare manufacturers.

Product overview

ICS is a pharmaceutical third-party logistics (3PL) brand operating as part of Cencora's global logistics network. The company provides a platform-plus-modules architecture consisting of core 3PL services (warehousing, storage, transport, and order fulfillment) augmented by specialized add-on modules including specialty/cold chain logistics, GMP repackaging, serialization, and cell/gene therapy logistics. Supporting brands within the Cencora family include Alloga (Europe), Innomar, and World Courier, with US operations branded as ICS. Additional solutions include Title Model services, full order-to-cash processing, fourth-party logistics (4PL), and import/export logistics support. The technology stack includes EDI integration for automated business document exchange, warehouse management systems, ERP integration, and multi-country portal capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Third-Party Logistics (3PL) Services Comprehensive pharmaceutical third-party logistics services providing warehousing, storage, transport, order fulfillment, and packaging/labeling solutions for pharmaceutical and healthcare manufacturers. US operations are powered by the ICS brand.
• Specialty Logistics Customized cold chain storage solutions for all product types and temperature requirements, including ambient to cryogenic temperatures, aerosols, hazardous goods, active pharmaceutical ingredients (APIs), and controlled drugs, plus a hub turnkey solution for pan-European distribution.
• Transport Solutions Domestic and international transportation of pharmaceutical products with temperature controls, GDP-compliant methods (trucks and air freight), and a track-and-trace portal providing live status updates, packing list visibility, and estimated time of arrival.
• Warehousing and Storage Solutions Sophisticated refrigeration systems, specialized handling procedures, and enhanced monitoring protocols that protect product integrity and patient safety, supported by efficient pick, pack, and ship operations.
• Order Fulfillment Services End-to-end order fulfillment including order-to-cash processes; clients can retain control of customer interactions while Cencora fulfills deliveries, or delegate the entire process from order receipt through sales collection.
• Packaging and Labeling Value-added services including repackaging, kitting, labeling, and quality inspection that streamline operations and reduce the need for multiple vendors.
• GMP Repacking and Relabeling Specialized repackaging and relabeling services delivered under good manufacturing practice (GMP) standards to uphold product integrity, patient safety, and quality.
• Cell and Gene Therapy (CGT) Logistics End-to-end storage and distribution solution for cell and gene therapy innovators to support the sale of advanced therapies.
• Pharmaceutical Serialization Services that maintain compliance with global serialization requirements while delivering products to patients more efficiently.
• Fourth-Party Logistics (4PL) Strategic, end-to-end supply chain management solutions that help pharmaceutical and healthcare organizations improve visibility, coordination, compliance, and operational performance. Available in Austria, Canada, Italy, Slovakia, and Switzerland.
• API and Controlled Drug Logistics Active pharmaceutical ingredient (API) supply chain and manufacturing logistics solutions designed to protect business continuity.
• Logistics Support for Import/Export Services helping pharmaceutical products move efficiently and compliantly across borders while mitigating risks and optimizing costs.
• Title Model Solutions Solutions for situations where speed to market, risk reduction, and expedited cash flow are mission-critical, available in Czech Republic, France, Germany, Netherlands, Lithuania, Norway, Portugal, Romania, Spain, UK, and US.
• Full Order-to-Cash Solution Supply chain and commercialization services that streamline operations and help manage risk for pharmaceutical manufacturers.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Four partnerships are on record, tiered core and expansion.

• AllogacoreOthersAlloga is part of the Cencora family of companies and powers European 3PL services. It provides comprehensive logistics solutions for pharmaceutical and healthcare manufacturers across Europe, with facilities in multiple countries.
• InnomarcoreOthersInnomar is part of the Cencora family of companies and supports 3PL operations, providing specialty logistics services within the global network.
• World CouriercoreOthersWorld Courier is part of the Cencora family of companies and supports global 3PL locations, providing specialized courier and transport services for pharmaceutical products.
• NextPharma LogisticsexpansionStrategic or Co-development PartnerNextPharma Logistics is a healthcare logistics provider that delivers services across Germany, Austria and Switzerland. Cencora is expanding its European logistics capabilities through this partnership.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• DHL Supply Chain (Life Sciences & Healthcare): DHL Supply Chain operates a large dedicated Life Sciences & Healthcare vertical with GDP-compliant warehousing, cold chain, and global distribution for pharmaceutical manufacturers — directly competing with ICS for pharma 3PL contracts.
• UPS Healthcare: UPS Healthcare (including Marken for clinical and CGT logistics) provides temperature-controlled pharmaceutical warehousing, distribution, and specialty courier services — directly comparable to ICS's pharma 3PL offering.
• Kuehne+Nagel (KN PharmaChain): Kuehne+Nagel operates KN PharmaChain, a global pharma and healthcare logistics platform offering GDP-compliant warehousing, cold chain, and forwarding services that compete directly with ICS.
• FedEx Custom Critical: FedEx Custom Critical and FedEx Healthcare Solutions provide time- and temperature-sensitive pharmaceutical logistics including cold chain air and ground services — overlapping with ICS's specialty transport capabilities.
• DB Schenker Life Sciences: DB Schenker operates a Life Sciences vertical offering GDP-compliant pharmaceutical warehousing and cold chain transport solutions across global markets, directly comparable to ICS.
• Movianto: Movianto is a dedicated pharmaceutical logistics provider offering warehousing, cold chain, and distribution services across Europe — a direct niche competitor to ICS's pharmaceutical 3PL model.
• Biocair: Biocair is a specialist life sciences logistics provider with deep expertise in cell and gene therapy, cryogenic transport, and clinical trial logistics — directly competing with ICS's CGT and specialty cold chain offerings.
• CEVA Logistics (Healthcare): CEVA Logistics operates a healthcare and life sciences vertical providing temperature-controlled warehousing, transport, and pharmaceutical distribution services comparable to ICS.
• XPO Logistics (Healthcare vertical): XPO Logistics offers healthcare and pharmaceutical logistics including cold chain warehousing and distribution, providing overlapping capabilities to ICS in pharma 3PL.

Emerging players

• Cryoport Systems: Cryoport Systems is a specialty life sciences logistics provider focused on temperature-controlled supply chains for cell and gene therapy, reproductive medicine, and biologics — overlapping with ICS's CGT and cryogenic logistics offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ICSConnect
• Facebookfacebook.com/ICSconnect.abc
• LinkedInlinkedin.com/company/icsconnect
• Instagraminstagram.com/cencoraglobal

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ICS